Laleh Melstrom, MD
Surgery · Duarte, CANPI 1811153893
Payments from drug & device makers
Across 19 payments — averaging $229.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Delcath Systems$3K
- Intuitive Surgical$1K
- Intera Oncology, Inc$259
- AstraZeneca$124
- Tersera Therapeutics LLC$38
- Tempus AI, Inc$29
- plus $34 from 2 others
What the payments were for
- Consulting fees$2,50057%
- Travel & lodging$89420%
- Food & beverage$97522%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Delcath Systems | 1 | $2,500 |
| Intuitive Surgical | 12 | $1,385 |
| Intera Oncology, Inc | 1 | $259 |
| AstraZeneca | 1 | $124 |
| Tersera Therapeutics LLC | 1 | $38 |
| Tempus AI, Inc | 1 | $29 |
| Bayer | 1 | $18 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hepzato Kit$2,500
- Da Vinci Surgical System$1,260
- Intera 3000 Implantable Pump$259
- LYNPARZA$124
How this compares
$4,369 in reported general payments places this provider in the 60th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 12 | $9,486 |
| Pantoprazole Sodium | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other surgery in Duarte
- Timothy ChuterSan Francisco$8.9M
- Peter StockSan Francisco$6.5M
- Santiago HorganSan Diego$2.8M
- Kenneth DeckLaguna Hills$2.4M
- Daniel RiskinSan Jose$2.2M
- Michael DemeureNewport Beach$1.7M
- Rock LiuHayward$1.6M
- David LouriePasadena$1.4M
- Andrea PakulaThousand Oaks$1.4M
- Siew-Ming LeeFresno$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.